Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...

After a disappointing phase 1 showing, Janux Therapeutics is kicking one of its bispecific T-cell engagers (TCEs) ...

A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page ...

RNA epigenetics also called Epitranscriptomics is an evolving field of research that explores chemical modifications on RNA and their impact on the cell and ...

A new Nature study reveals how the heart’s constant beating may block cancer cell growth. This rare natural defence could ...

A University of Lausanne lab study suggests biotin, a vitamin often taken for hair and nail health, may enable cancer cells to grow in glutamine-deficient conditions by activating an alternative ...

Scientists have captured the most detailed structural images to date of a specific type of protein's DNA repair process, a ...

Parents, cancer survivors and advocates for pediatric cancer research made an emotional plea for funding at the Iowa ...

After surviving leukemia and undergoing a stem cell transplant, Allan Jones is now volunteering on the very same floor where ...

Becca Behler thought she had her life and career in front of her. It was early summer in 2020, and Becca had recently ...

Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.

Combining cord blood transplant with a pooled stem cell product to treat blood diseases shows promise in improving efficacy, safety and accessibility for patients needing a stem cell transplant.